Participation and crowd-out in a Medicare drug benefit: simulation estimates

Area of Science:

• Health Economics
• Public Policy
• Behavioral Economics

Background:

• Medicare beneficiaries face complex decisions regarding prescription drug coverage.
• Understanding participation drivers and potential 'crowd-out' effects is crucial for policy evaluation.

Purpose of the Study:

• To estimate likely participation in the Medicare prescription drug plan.
• To assess the expected 'crowd-out' of private drug spending.
• To analyze the impact of behavioral parameters on participation and crowd-out.

Main Methods:

• Microsimulation modeling using data from the Medicare Current Beneficiary Survey (MCBS).
• Simulations varied benefit levels, subsidies, and behavioral parameters (moral hazard, risk aversion).
• Estimation of costs, benefits, and risk reduction associated with the drug plan.

Main Results:

• Participation and crowd-out levels are sensitive to benefit design and subsidy levels.
• Higher moral hazard and lower risk aversion decrease net participation.
• The model quantifies the trade-offs between plan generosity and behavioral responses.

Conclusions:

• Policy design significantly influences Medicare drug plan uptake and market effects.
• Behavioral economics principles are essential for accurate prediction of program outcomes.
• Further research should refine estimates of behavioral parameters in Medicare populations.